N4 Pharma Share Discussion Threads

[bones] 14/7/2017 09:03

TT, I'd say the main sub 100k sellers are "loss-takers" rather than making profits. They've piled in at 12p and got their timing wrong because the market in more racey shares has fallen off a cliff since the election in early June. The bigger players have taken risk off the table. The warrant holders from Onzima days have probably also bailed en masse as they are not really committed and saw their 8p price going underwater.It's not N4P in isolation. I keep an eye on and have interests in several small shares and they have all dropped 30% or more since May. The market is off but I bet it comes back when the players return from their holibobs.To that extent, you can say "backtofront" has it right when he says the market is avoiding risk assets although he is going for the big drop scenario.My average on N4P is 8.8p with most bought well before the share even went up to 12p but I did top up 100k this week at 7.45p as mentioned at the time. Plus I am looking ahead a year or two with this one.Whatever, I am holding and relaxed and I will be even if it drops to 5p. I don't have all my money in this one share by any means.

[trotterstrading] 14/7/2017 08:33

Guys, give it a chance ffs! It only been listed a few months! We know the cause of the share price decline, a combination of IPO holders at 7p taking a nice profit, legacy OZM holders who were locked in for months and profit takers from the race up to 12p. Can't be many sellers left making a profit at current levels so the selling will dry up soon enough, when it does the book will flip and we're back to sensible levels, which in my view is c.10p in Lieu of news

[pennyfalls] 14/7/2017 00:57

There is no obvious charting, I agree...
but there were times when it didn't hold that are "sell" signals as we fell down..
that was when it didn't hold the upwards bounce at circa 10p and again at just under 8.5p..

There's no hindsight charting, just points where pro traders would have sold.

[zebbo] 13/7/2017 21:23

I like to deal in specifics

1. No funding required prior commercial outcome of Sildenafil (Viagra) - with market sales of approx $4.6 billion in
2016 (Q3/4 2016)
2. 4 other multi £B reformulation prospects and growing, all with top quality IP
3. 2 new vaccine delivery mechanisms, again with mass market appeal. 1 ready for commercialisation in Q3
4. CEO owns 16% of the stock
5. Low mkt cap Vs potential

FYB

[escapetohome] 13/7/2017 18:40

Big pharma circling at this price?

Go on you know you want to!

[escapetohome] 13/7/2017 18:39

Theres no way on earth im selling.

Im no fool and despite all the ramps, i just invested a small amount, no shakes if it continues to fall.

I like the products, i belive in their future, i believe in the management, thats why in vested.

I have 5 years timeframe.

Only a fool would sell.

[cufes2] 13/7/2017 18:13

I would have been impressed with anyone who had come here and said it was a sell when the share price was 12p, 11p, hell, even 9p . . . But 8p in a downtrend doesn't make you a guru IMHO . . .

[pennyfalls] 13/7/2017 18:01

Only thing to really worry about is if ShareProhpets et al get their teeth into it, with cohorts. Maybe backtogo has an agenda, maybe now. Who cares. He's statig the obvious...it's not hard to see. Just that people seem to react against obvious historic trends - that are right before your eyes.

All I'm saying is that the chart is pretty obvious. Where';s the support? At just over 6p.
If that goes then I think there will be mass panic selling. There is probably quite a lot of panis selling at the moment. Hoping for a double-bottom bounce around 6p+

As for shorting..I don't know if some small caps like this can be shorted. Some can't.

[luminoso] 13/7/2017 16:54

I don't think backtogo is a troll. I think 'any buffoon with no brain' can probably see that he has an agenda, possibly a short, to see this fall further. Why spend so much time on here posting the same message otherwise ?
Any buffoon with no brain can also see that the best stocks to attack are those that have already fallen from their highs, making it easy to encourage further selling through fear.
Of course backtogo may be right, and of course, the chart's trend is always right...... erm, until it isn't. Then again, he may be wrong.

[escapetohome] 13/7/2017 16:03

" Even a buffon with no brain can see hes right "

I am a buffon with no brain, and i dont think hes right.

[pennyfalls] 13/7/2017 16:00

I find the bull-headed dogma of traders hard to fathom and totally immature - that;s why most lose money..
Most people on here play the man not the ball (ad hominem) ...and take all "attacks " as being personal; defending their investment like children.

Liston, I don't really care who "backtogo" is, and don't particularly like the way the share is going (price) but even a buffoon with no brain can see he is right.

The chart is TERRIBLE!!! This ia going lower, and I agree with his cheerleader sentiments.

Best to be a man and admit, like I am, that I've got it wrong in the short term and should have sold at 12p. That's the irrefutable truth. Most can't face their own failures.

Wherever this goes long term, it is guaranteed there will be fundraisers. N4P have themselves said that commercialisation is likely END 2017 for some products. and Viagra 2018..So in their own words, this has a long way to go - with nothing holding the price up - until the next ramp brigade get on board.

So I don't know why you're wasting you're time having a go at the silly little kid, as he's right, and you and I are wrong. The chart says it all.

[cufes2] 13/7/2017 12:03

20/20 hindsight is a wonderful attribute . . . Particularly when you predict the share price is going to fall and it already had done from 12p to 8p when you started posting here . . . Well done . . .

[backtogo] 13/7/2017 11:27

Do you think when sentiment changes you're not going to get a chance of being in?When this "multibags" like people think it will, do you think that's going to happen in a one minute move and you completely miss it?The time isn't right here. Plenty time.The "don't want to miss out" crowd are about to be scorched.

[backtogo] 13/7/2017 11:24

There lies the problem.You shouldn't be trying to beat the market at its own game. There's far more knowledge and money than you have, working away behind the scenes. You're at a huge disadvantage.You should be following the market. Sentiment is everything. Second guessing leads to poverty.The chart from June tells you everything you need to know. Below IPO is on the way.

[biggest bill] 13/7/2017 10:08

TT, it's probably best not to respond to the troll. All he craves is attention.

[trotterstrading] 13/7/2017 10:02

In the short term the 'market' is far from an effective mechanism for valuation, spotting unrealized value is the key to beating the market, otherwise you may as well buy a tracker fund and be done with it.

Let see where we are in a month from now, my guess is considerably higher than current SP

[backtogo] 13/7/2017 09:53

"Any fool could tell you this company is grossly undervalued at £5m!"LOLDoes the market believe that? It's all that matters.Fools and their money.

[cufes2] 12/7/2017 13:16

And a list of patents for products that require much less development and are cheaper to commercialise than new treatments . . .

[trotterstrading] 12/7/2017 13:13

Building Nicely, Any fool could tell you this company is grossly undervalued at £5m! Mcap could easily double and not stretch the realms of imagination IMHO

[scyther] 12/7/2017 11:36

Which pharma stock can u buy at £5mil mcap with revenues and guaranteed future income?

[trotterstrading] 12/7/2017 09:53

Solid open, can't be many more sellers left at current levels, I think the last of the 7's will go today

[backtogo] 12/7/2017 08:35

risk reward play LOL= mindless punt on a company with no revenue and no guarantee of any future revenues

[zebbo] 12/7/2017 07:53

Cu, second your comments, plus on a simple risk reward play this is very cheap indeed

[cufes2] 12/7/2017 07:19

The business model is not that of a typical pharma . . . The lead times to commerciality are much shorter and cheaper than normal . . . The company raised money recently . . . The CEO owns a significant amount of the company purchased on the open market . . . Unlike many AIM companies the CEO is much more aligned with PIs . . .